Related Experiment Video
Updated: Apr 6, 2026
05:28
Author Spotlight: Unveiling the Molecular Basis of Pain Perception and Neuropathic Pain
Published on: August 9, 2024
1.8K
Procognitive Compounds Promote Neurite Outgrowth.
Matthew Page1, Nathalie Pacico, Sadia Ourtioualous
1Translational Bioinformatics, UCB Pharma SA, Slough, UK.
Pharmacology
|August 1, 2015
Summary
This study tested compounds for Alzheimer's disease treatment potential. Some procognitive drugs promoted neurite growth, suggesting a possible disease-modifying effect beyond cognitive enhancement.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Current Alzheimer's disease treatments primarily offer cognitive enhancement.
- These treatments do not halt disease progression, necessitating disease-modifying drug development.
Purpose of the Study:
- To evaluate the neuritogenic potential of various procognitive compounds.
- To identify compounds that may promote neuronal growth and survival.
Main Methods:
- Primary neuronal cultures were utilized.
- Procognitive compounds were screened for their effect on neuritogenesis.
Main Results:
- Donepezil, memantine, dimebon, Pre-084, and 4-IBP demonstrated neuritogenic properties.
- Tacrine, rosemarinic acid, memoquin, and a BACE1 inhibitor inhibited neurite outgrowth.
Conclusions:
- Certain procognitive compounds exhibit potential for modifying Alzheimer's disease progression.
- Findings suggest a possible role for these compounds in neuroprotection.
Related Concept Videos
01:25Long-term Potentiation
3.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.9K
01:35Long-term Potentiation
59.6K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
59.6K
01:29Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
01:01Neuroplasticity
2.5K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.5K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
869
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
869
01:15Neurogenesis and Regeneration of Nervous Tissue
2.1K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.1K